Skip to content

Comparing Two Nerve Block Techniques for Treating Chronic Refractory Migraine: A Clinical Trial

Comparative evaluation of Ultrasound guided stellate ganglion versus sphenopalatine ganglion blockade for the treatment of patients with chronic refractory migraine: an open label randomized controlled trial. - nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085036
Enrollment
502
Registered
2025-04-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G437- Chronic migraine without aura Health Condition 2: G437- Chronic migraine without aura

Interventions

Intervention1: Ultrasound Guided Sphenopalatine Ganglion Block : Patients were sedated and positioned with the head turned to the opposite side using a linear ultrasound probe placed infrazygomaticall

Sponsors

Dr Ajit Kumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age between 18 and 60 years Diagnosed with migraine by expert physicians Diagnoses made according to International Classification of Headache Disorders criteria Pain unresponsive to conservative treatment including medical management physical therapy and previous interventions Average pain score of 4 or more on an 11 point Numerical Rating Scale Competent to understand the study protocol willing to provide voluntary written informed consent and willing to participate in the assessment of outcome measurements

Exclusion criteria

Exclusion criteria: Patient refusal Pain for less than 6 months Patients with a space occupying lesions in radiological investigations CT or MRI Patients with bilateral migraine attacks Coagulopathy and or patients on anticoagulants. Infection at the site of injection. Hypersensitivity to local anesthetic agent. Evidence of severe psychiatric illness. Uncontrolled or unstable opioid use Any conditions that might compromise the interpretation of outcome assessments. Pregnancy or lactation. History of any major comorbid medical conditions those interfere with recording of study outcomes neurological disorders auto-immune diseases multiple sclerosis.

Design outcomes

Primary

MeasureTime frame
Pain relief as assessed by Migraine disability assessment score MIDAS Annexure I at baseline and at 3 months after the procedureTimepoint: at baseline and at 3 months after the procedure

Secondary

MeasureTime frame
Pain relief as assessed by Numerical Rating Scale NRS on a scale of 1 to 10 Analgesic usage Procedural complications if any Timepoint: at baseline 1 month and at 3 months after the procedure

Countries

India

Contacts

Public ContactProf Dr Ajit Kumar

All India Institute of medical sciences Rishikesh

ajitdr.ajit@gmail.com9910789377

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026